MERCK & CO., INC. (MRK)
Clinical trial NCT03245411 updates: 1. completion date: 2025-12-20 → 2026-12-31 2. primary completion date: 2025-12-20 → 2026-09-30 3. enrollment: not set → 110 participants
Clinical trial NCT03245411 updates: 1. completion date: 2025-12-20 → 2026-12-31 2. primary completion date: 2025-12-20 → 2026-09-30 3. enrollment: not set → 110 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical